| Literature DB >> 28854891 |
Tomi Akinyemiju1,2,3, Howard Wiener4, Maria Pisu5,6.
Abstract
BACKGROUND: Racial disparities in the incidence of major cancers may be attributed to differences in the prevalence of established, modifiable risk factors such as obesity, smoking, physical activity and diet.Entities:
Keywords: Cancer incidence; Cancer-related risk factors; Diet; Obesity; Physical activity
Mesh:
Year: 2017 PMID: 28854891 PMCID: PMC5577755 DOI: 10.1186/s12885-017-3557-1
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Cancer related risk factors adherence criteria
| Risk Factor | Adherence Guideline | Adherence Score |
|---|---|---|
| Physical Activity (# of 20 min activities) | ≥5 per week | 1 |
| ≥1 per month - < 5 per week | 0.5 | |
| <1 per month | 0 | |
| Obesity (BMI) | ≥18.5 - ≤ 25 kg/m2 | 1 |
| >25 - ≤ 30 kg/m2 | 0.5 | |
| <18.5 or >30 kg/m2 | 0 | |
| Alcohol Use (# drinks per week) | Women ≤7, Men ≤14 | 1 |
| Women >7 - ≤ 14, Men >14 ≤ 28 | 0.5 | |
| Women >14, Men >28 | 0 | |
| Nutrition (Fruit and Vegetable Servings per day) | ≥5 | 1 |
| ≥3 - < 5 | 0.5 | |
| <3 | 0 |
Baseline Characteristics of NIH-AARP Study Participants, 1995-1996
| Overall | White | AA | |
|---|---|---|---|
| Age Category | |||
| < 55 years | 64,491 (13.71%) | 61,318 (13.61%) | 3173 (16.13%) |
| 55-59 years | 106,893 (22.73%) | 101,588 (22.54%) | 5305 (26.96%) |
| 60-64 years | 132,005 (28.07%) | 126,108 (27.99%) | 5897 (29.97%) |
| 65-69 years | 150,255 (31.95%) | 145,423 (32.27%) | 4832 (24.56%) |
| > =70 years | 16,656 (3.54%) | 16,186 (3.59%) | 470 (2.39%) |
| Gender | |||
| Male | 280,558 (59.66%) | 272,444 (60.46%) | 8114 (41.24%) |
| Female | 189,742 (40.34%) | 178,179 (39.54%) | 11,563 (58.76%) |
| Marital Status | |||
| Married | 323,303 (69.11%) | 314,122 (70.05%) | 9181 (47.27%) |
| Widowed | 51,660 (11.04%) | 48,293 (10.77%) | 3367 (17.34%) |
| Divorced | 64,882 (13.87%) | 60,310 (13.45%) | 4572 (23.54%) |
| Separated | 5483 (1.17%) | 4445 (0.99%) | 1038 (5.34%) |
| Never Married | 22,508 (4.81%) | 21,244 (4.74%) | 1264 (6.51%) |
| Education | |||
| < 8 years | 27,821 (6.07%) | 25,646 (5.83%) | 2175 (11.66%) |
| 8-11 years | 93,358 (20.37%) | 89,446 (20.35%) | 3912 (20.98%) |
| 12 years/High School | 46,651 (10.18%) | 44,926 (10.22%) | 1725 (9.25%) |
| Post-High School/Some College | 109,302 (23.85%) | 104,369 (23.74%) | 4933 (26.46%) |
| College or post-grad | 181,132 (39.53%) | 175,231 (39.86%) | 5901 (31.65%) |
| Health Status | |||
| Excellent | 81,207 (17.50%) | 79,438 (17.86%) | 1769 (9.20%) |
| Very good | 166,103 (35.80%) | 160,658 (36.13%) | 5445 (28.31%) |
| Good | 160,182 (34.53%) | 152,225 (34.23%) | 7957 (41.37%) |
| Fair | 48,823 (10.52%) | 45,256 (10.18%) | 3567 (18.55%) |
| Poor | 7641 (1.65%) | 7145 (1.61%) | 496 (2.58%) |
| State of Residence | |||
| CA | 139,633 (29.69%) | 135,081 (29.98%) | 4552 (23.13%) |
| FL | 100,509 (21.37%) | 98,147 (21.78%) | 2362 (12.00%) |
| GA | 13,663 (2.91%) | 12,468 (2.77%) | 1195 (6.07%) |
| LA | 18,225 (3.88%) | 16,901 (3.75%) | 1324 (6.73%) |
| MI | 24,420 (5.19%) | 22,254 (4.94%) | 2166 (11.01%) |
| NC | 39,889 (8.48%) | 37,678 (8.36%) | 2211 (11.24%) |
| NJ | 60,484 (12.86%) | 57,755 (12.82%) | 2729 (13.87%) |
| PA | 73,477 (15.62%) | 70,339 (15.61%) | 3138 (15.95%) |
| Cancer Type | |||
| Any Cancer | 114,392 (24.33%) | 109,971 (23.99%) | 4421 (22.47%) |
| Breast Cancer | 12,698 (6.70%) | 12,020 (6.75%) | 678 (5,87%) |
| Prostate Cancer | 30,664 (10.93%) | 29,222 (10.73%) | 1442 (17.77%) |
| Colorectal Cancer | 10,300 (2.19%) | 9845 (2.19%) | 455 (2.31%) |
For breast and prostate cancer, the percentages in the above table are based on females only and males only, respectively
Fig. 1Distribution of adherence components by race and gender, stratified by region, NIH-AARP Diet and Health Study
Adherence to Specific Cancer Risk Factors by Race, Gender and Region, NIH-AARP Diet and Health Study (%a)
| Obesity | Alcohol | Smoking | Nutrition | Physical Activity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0.5 | 1 | 0 | 0.5 | 1 | 0 | 0.5 | 1 | 0 | 0.5 | 1 | 0 | 0.5 | 1 | |
| Overall | 21.71 | 42.96 | 35.33 | 0.29 | 0.85 | 98.85 | 11.89 | 51.82 | 36.29 | 36.54 | 37.75 | 25.71 | 20.57 | 56.81 | 22.61 |
| Gender | |||||||||||||||
| Male | 20.47 | 49.87 | 29.66 | 0.40 | 1.15 | 98.45 | 10.37 | 59.29 | 30.34 | 35.40 | 38.17 | 26.43 | 16.91 | 58.25 | 24.84 |
| Female | 23.59 | 32.49 | 43.92 | 0.13 | 0.40 | 99.47 | 14.20 | 40.49 | 45.31 | 38.26 | 37.13 | 24.61 | 26.13 | 54.63 | 19.24 |
| Race | |||||||||||||||
| White | 21.21 | 42.96 | 35.83 | 0.29 | 0.85 | 98.86 | 11.74 | 52.10 | 36.15 | 36.73 | 38.07 | 25.20 | 20.27 | 56.95 | 22.78 |
| AA | 34.27 | 42.99 | 22.74 | 0.34 | 0.92 | 98.74 | 15.58 | 44.74 | 39.68 | 31.85 | 29.87 | 38.28 | 28.10 | 53.37 | 18.53 |
| Region | |||||||||||||||
| Midwest | 26.46 | 42.98 | 30.55 | 0.35 | 0.79 | 98.87 | 13.19 | 50.95 | 35.86 | 36.91 | 37.37 | 25.72 | 24.21 | 56.97 | 18.81 |
| North East | 23.58 | 44.34 | 32.09 | 0.26 | 0.76 | 98.97 | 11.69 | 50.45 | 37.86 | 33.38 | 38.61 | 28.01 | 23.70 | 56.48 | 19.83 |
| South | 20.95 | 43.20 | 35.85 | 0.33 | 0.96 | 98.71 | 12.92 | 52.97 | 34.11 | 38.96 | 36.90 | 24.15 | 19.58 | 57.01 | 23.41 |
| West | 20.11 | 41.38 | 38.51 | 0.29 | 0.89 | 98.83 | 10.60 | 51.83 | 37.56 | 36.46 | 38.07 | 25.47 | 18.27 | 56.86 | 24.87 |
| Race-Gender | |||||||||||||||
| White Males | 20.27 | 49.87 | 29.85 | 0.40 | 1.14 | 98.46 | 10.23 | 59.41 | 30.36 | 35.44 | 38.38 | 26.18 | 16.73 | 58.31 | 24.96 |
| White Females | 22.66 | 32.16 | 45.18 | 0.12 | 0.40 | 99.48 | 14.12 | 40.68 | 45.21 | 38.74 | 37.59 | 23.67 | 25.81 | 54.82 | 19.37 |
| AA Males | 27.55 | 49.68 | 22.76 | 0.45 | 1.52 | 98.03 | 15.50 | 54.89 | 29.61 | 34.01 | 30.66 | 35.33 | 23.46 | 56.04 | 20.50 |
| AA Females | 39.22 | 38.06 | 22.72 | 0.25 | 0.48 | 99.27 | 15.63 | 37.26 | 47.10 | 30.27 | 29.29 | 40.44 | 31.52 | 51.39 | 17.09 |
Risk factors defined based on WCRF/AICR criteria for adherence; 0 if not met, 0.5 if partially met and 1.0 if fully met
aProportion of study participants at each level of adherence
Association between Adherence and Any, Breast, Colorectal and Prostate Cancer Incidence by Race, NIH-AARP Diet and Health Study
| Any Cancer HR (95% CI) | Breast Cancer HR (95% CI) | Prostate Cancer HR (95% CI) | Colorectal Cancer HR (95% CI) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | White | AA | All | White | AA | All | White | AA | All | White | AA | |
| Obesity | ||||||||||||
| 0 | 1.08 (1.06 -1.1) | 1.08 (1.06 - 1.1) | 0.91 (0.83 - 0.99) | 1.16 (1.1 - 1.22) | 1.14 (1.09 - 1.2) | 1.1 (0.89 - 1.37) | 0.87 (0.84-0.89) | 0.87 (0.84 -.89) | 0.89 (0.76 - 1.03) | 1.3 (1.22 - 1.38) | 1.29 (1.2-1.37) | 1.09 (0.83 - 1.43) |
| 0.5 | 1.04 (1.03 -1.05) | 1.04 (1.03 -1.05) | 0.95 (0.91 - 0.99) | 1.08 (1.05 - 1.1) | 1.07 (1.04 -1.09) | 1.05 (0.94 - 1.17) | 0.93 (0.91-0.95) | 0.93 (0.92 -0.95) | 0.94 (0.87 - 1.02) | 1.14 (1.11 -1.17) | 1.14 (1.11 -1.17) | 1.04 (0.91 - 1.2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Alcohol | ||||||||||||
| 0 | 1.55 (1.43 -1.68) | 1.54 (1.44 -1.66) | 1.64 (1.16 - 2.31) | 1.78 (1.26 - 2.51) | 1.5 (1.07 - 2.09) | 2.71 (1.06 - 6.9) | 1.08 (0.92 -1.27) | 1.04 (0.89 - 1.2) | 1.05 (0.56 - 1.95) | 2.02 (1.59 -2.58) | 1.99 (1.59 -2.47) | 3.64 (1.6 - 8.27) |
| 0.5 | 1.24 (1.19 -1.29) | 1.24 (1.2 -1.29) | 1.28 (1.08 - 1.52) | 1.33 (1.12 - 1.59) | 1.22 (1.04 -1.45) | 1.64 (1.03 - 2.63) | 1.04 (0.96 -1.13) | 1.02 (0.94 - 1.1) | 1.02 (0.75 - 1.4) | 1.42 (1.26 -1.61) | 1.41 (1.26 -1.57) | 1.91 (1.27 - 2.88) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Smoking | ||||||||||||
| 0 | 1.68 (1.65 -1.72) | 1.7 (1.67 - 1.74) | 1.63 (1.49 - 1.79) | 1.11 (1.05 - 1.18) | 1.12 (1.06 -1.18) | 1.28 (1.02 - 1.6) | 0.83 (0.79 -0.86 | 0.82 (0.79 - .86) | 0.88 (0.75 - 1.05) | 1.41 (1.32 -1.51) | 1.42 (1.33 -1.51) | 1.3 (0.97 - 1.73) |
| 0.5 | 1.3 (1.28 -1.31) | 1.31 (1.29 -1.32) | 1.28 (1.22 - 1.34) | 1.06 (1.03 - 1.09) | 1.06 (1.03 -1.09) | 1.13 (1.01 - 1.27) | 0.91 (0.89-0.93) | 0.91 (0.89 -0.93) | 0.94 (0.86 - 1.02) | 1.19 (1.15 -1.23) | 1.19 (1.15 -1.23) | 1.14 (0.99 -1.31) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nutrition | ||||||||||||
| 0 | 1.11 (1.09 -1.13) | 1.11 (1.1 - 1.13) | 1.09 (1.01 - 1.17) | 1.07 (1.01 - 1.12) | 1.07 (1.02 -1.12) | 1.13 (0.94 - 1.37) | 1.02 (0.99 -1.05) | 1.02 (0.99 -1.05) | 0.93 (0.82 - 1.06) | 1.13 (1.07 -1.19) | 1.13 (1.08 - 1.2) | 1.15 (0.92 - 1.44) |
| 0.5 | 1.05 (1.04 -1.06) | 1.05 (1.05 -1.06) | 1.04 (1.01 - 1.08) | 1.03 (1.01 - 1.06) | 1.04 (1.01 -1.06) | 1.06 (0.97 - 1.17) | 1.01 (0.99 -1.03) | 1.01 (0.99 -1.03) | 0.96 (0.91 - 1.03) | 1.06 (1.03 -1.09) | 1.07 (1.04 -1.09) | 1.07 (0.95 - 1.2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Physical Activity | ||||||||||||
| 0 | 1.15 (1.13 -1.18) | 1.15 (1.13 -1.17) | 1.18 (1.07 - 1.3) | 1.12 (1.05 - 1.19) | 1.11 (1.05 -1.18) | 1.28 (0.99 - 1.67) | 0.94 (0.90-0.97) | 0.92 (0.88 -0.95) | 1.04 (0.87 - 1.24) | 1.33 (1.24 -1.42) | 1.35 (1.26 -1.44) | 1.15 (0.85 -1.56) |
| 0.5 | 1.07 (1.06 -1.09) | 1.07 (1.06 -1.08) | 1.09 (1.03 - 1.14) | 1.06 (1.03 - 1.09) | 1.05 (1.02 -1.09) | 1.13 (0.99 - 1.29) | 0.97 (0.95-0.99) | 0.96 (0.94 -0.98) | 1.02 (0.93 - 1.11) | 1.15 (1.11 -1.19) | 1.16 (1.12 - 1.2) | 1.07 (0.92 - 1.25) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Overall Adherence | ||||||||||||
| 1 | 1.76 (1.7 -1.82) | 1.76 (1.7 - 1.82) | 1.69 (1.42 - 2) | 1.38 (1.26 - 1.52) | 1.38 (1.25 -1.52) | 1.45 (0.93 - 2.25) | 0.79 (0.75-0.85) | 0.70 (0.74 -0.84) | 0.98 (0.73 - 1.33) | 2.06 (1.84 -2.29) | 2.07 (1.86 -2.32) | 1.64 (0.96 - 2.79) |
| 2 | 1.53 (1.49 -1.56) | 1.53 (1.49 -1.57) | 1.48 (1.3 - 1.68) | 1.28 (1.19 - 1.37) | 1.27 (1.19 -1.37) | 1.32 (0.95 - 1.84) | 0.84 (0.80-0.88) | 0.84 (0.79 -0.88) | 0.98 (0.79 - 1.24) | 1.72 (1.58 -1.86) | 1.73 (1.59 -1.88) | 1.45 (0.97- 2.16) |
| 3 | 1.33 (1.3 -1.35) | 1.33 (1.31 -1.35) | 1.31 (1.19 - 1.42) | 1.18 (1.12 - 1.23) | 1.18 (1.12 -1.23) | 1.2 (0.96 - 1.5) | 0.89 (0.86-0.92) | 0.89 (0.86 -0.92) | 0.99 (0.85 - 1.15) | 1.43 (1.36 -1.51) | 1.44 (1.36 -1.52) | 1.28 (0.98 - 1.67) |
| 4 | 1.15 (1.14 -1.16) | 1.15 (1.14 -1.16) | 1.14 (1.09 - 1.19) | 1.08 (1.06 - 1.11) | 1.08 (1.06 -1.11) | 1.1 (0.98 - 1.23) | 0.94 (0.93-0.96) | 0.94 (0.93 -0.96) | 0.99 (0.92 - 1.07) | 1.2 (1.17 - 1.23) | 1.2 (1.17 - 1.23) | 1.13 (0.99 - 1.29) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All models estimated using Cox Proportional Hazards regression and adjusted for age, gender (for colorectal cancer), marital status, and education
Abbreviations: CI confidence interval, AA African-Americans
Fig. 2Multivariable adjusted hazard ratios (HR, 95% CI) for adherence and cancer incidence, stratified by race, NIH-AARP Diet and Health Study
Association (HR, 95% CI) between Adherence and Any, Breast, Colorectal and Prostate Cancer Incidence by Region, NIH-AARP Diet and Health Study
| Adherence | All | Mid-West | North East | South | West |
|---|---|---|---|---|---|
| Any Cancer | |||||
| 1 | 1.88 (1.82 - 1.95) | 1.84 (1.59 - 2.14) | 2.03 (1.91 - 2.17) | 1.98 (1.87 - 2.10) | 1.64 (1.54 - 1.75) |
| 2 | 1.61 (1.57 - 1.65) | 1.58 (1.41 - 1.77) | 1.70 (1.63 - 1.79) | 1.67 (1.60 - 1.75) | 1.45 (1.38 - 1.52) |
| 3 | 1.37 (1.35 - 1.4) | 1.36 (1.26 - 1.46) | 1.43 (1.38 - 1.47) | 1.41 (1.37 - 1.45) | 1.28 (1.24 - 1.32) |
| 4 | 1.17 (1.16 - 1.18) | 1.17 (1.12 - 1.21) | 1.19 (1.18 - 1.21) | 1.19 (1.17 - 1.20) | 1.13 (1.11 - 1.15) |
| 5 | Ref | Ref | Ref | Ref | Ref |
| Breast Cancer | |||||
| 1 | 1.44 (1.30 - 1.59) | 2.03 (1.32 - 3.12) | 1.53 (1.26 - 1.85) | 1.36 (1.15 - 1.61) | 1.38 (1.16 - 1.64) |
| 2 | 1.31 (1.22 - 1.42) | 1.70 (1.23 - 2.35) | 1.37 (1.19 - 1.59) | 1.26 (1.11 - 1.43) | 1.27 (1.12 - 1.45) |
| 3 | 1.20 (1.14 - 1.26) | 1.42 (1.15 - 1.77) | 1.24 (1.12 - 1.36) | 1.17 (1.07 - 1.27) | 1.17 (1.08 - 1.28) |
| 4 | 1.10 (1.07 - 1.12) | 1.19 (1.07 - 1.33) | 1.11 (1.06 - 1.17) | 1.08 (1.04 - 1.13) | 1.08 (1.04 - 1.13) |
| 5 | Ref | Ref | Ref | Ref | Ref |
| Prostate Cancer | |||||
| 1 | 0.77 (0.72 - 0.83) | 0.82 (0.62 - 1.08) | 0.77 (0.68 - 0.87) | 0.79 (0.71 - 0.89) | 0.75 (0.66 - 0.85) |
| 2 | 0.82 (0.78 - 0.87) | 0.86 (0.70 - 1.06) | 0.83 (0.75 - 0.90) | 0.84 (0.77 - 0.91) | 0.80 (0.73 - 0.88) |
| 3 | 0.88 (0.85 - 0.91) | 0.91 (0.79 - 1.04) | 0.88 (0.83 - 0.94) | 0.89 (0.84 - 0.94) | 0.86 (0.81 - 0.92) |
| 4 | 0.94 (0.92 - 0.95) | 0.95 (0.89 - 1.02) | 0.94 (0.91 - 0.97) | 0.94 (0.92 - 0.97) | 0.93 (0.90 - 0.96) |
| 5 | Ref | Ref | Ref | Ref | Ref |
| Colorectal Cancer | |||||
| 1 | 2.24 (2.00 - 2.52) | 3.43 (2.00 - 5.88) | 2.64 (2.16 - 3.24) | 2.27 (1.87 - 2.75) | 1.72 (1.39 - 2.14) |
| 2 | 1.83 (1.68 – 2.00) | 2.52 (1.68 - 3.78) | 2.07 (1.78 - 2.41) | 1.85 (1.60 - 2.13) | 1.50 (1.28 - 1.77) |
| 3 | 1.50 (1.41 - 1.59) | 1.85 (1.42 - 2.42) | 1.63 (1.47 - 1.80) | 1.51 (1.37 - 1.66) | 1.31 (1.18 - 1.46) |
| 4 | 1.22 (1.19 - 1.26) | 1.36 (1.19 - 1.56) | 1.27 (1.21 - 1.34) | 1.23 (1.17 - 1.29) | 1.15 (1.09 - 1.21) |
| 5 | Ref | Ref | Ref | Ref | Ref |
All models estimated using Cox Proportional Hazards regression and adjusted for age, race, gender (for any and colorectal cancer), marriage (ever, current), education (high school, college degree), and state (for all regions, and multi-state regions)
Fig. 3Attributable fraction (%, 95% CI) for adherence by race and cancer type